Nice | Familial breast cancer

18th July 2013 by Louise Hudman

This familial breast cancer guideline doesn’t change anything for us. Our role is to risk assess women and refer on to the genetics services if they may be at high risk. NICE do say that this shouldn’t be screening, but a response to a concerned woman, or if there seems to be a significant history on doing a pill or HRT check.

Also of interest is that ‘TP53’ is now tested for, alongside BRCA1 and 2

How to do a familial breast cancer risk assessment

This hasn’t changed from the last guideline. There was a handy flowchart in the last guideline, which I keep printed out to use.

Combined oral contraceptive (COC) use

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I am a newly qualified sessional GP. I am thankful to you and your team for the splendid work you do for all of us. LocumDeck is the only platform that allows GPs to be in control and I am glad I have been a member of NASGP since my trainee days."

Dr Karthik Krishna

See the full list of features within our NASGP membership plans

Membership